The national Ending the HIV Epidemic initiative, proposed by the U.S. Department of Health and Human Services, employs four key strategies to reduce new HIV infections by 90% by 2030 and end the HIV epidemic in the U.S.

Pillar One: Diagnose all people with HIV as early as possible

Pillar Two: Treat people with HIV rapidly and effectively to reach sustained viral suppression

Pillar Three: Prevent new HIV transmissions using proven interventions, including PrEP and syringe services program

Pillar Four: Respond quickly to potential HIV outbreak to get needed prevention and treatment services to people who need them

Provider Registration

MM slash DD slash YYYY

acknowledge that DOH-Miami-Dade has visited our practice and provided resources regarding the ongoing effort to eliminate HIV transmission and reduce HIV-related deaths, including but not limited to, printed educational and informational materials for distribution to my patients at no cost. I also acknowledge that I have been explained how to make appropriate referrals for any services I do not provide in my practice.

Activity Details

Which activities would your clinical care site agree to implement? Please check all that apply

Please refer to Activity Details below(Required)
Which activities would your clinical care site agree to implement?

Activity Details

Routine HIV Testing, According to Section 381.004, Florida Statutes

The CDC recommends that individuals ages 13-64 get tested for HIV at least once as part of routine health care, and that those with risk factors get tested more frequently. Patients who may be at high risk for HIV should be screened at least annually. The Department of Health will return in 6 months to provide any further assistance needed on the implementation of routinized HIV testing.

In July 2015, the Florida HIV testing law was amended to allow opt-out testing. The amendment to section 381.004, F.S. removed the need for separate informed consent prior to HIV testing in health care settings. Patients must be notified either verbally or in writing that they will be tested for HIV, unless they decline testing. Notification must include information that a positive HIV test result, along with identifying information, will be reported to the county health department and of the availability and location of sites at which anonymous testing is performed.

The Florida Department of Health recommends including a fourth-generation antigen/antibody test on all routine lab testing for clients that are sexually active.

Provide PrEP/nPEP Clinical Care

PrEP and nPEP are biomedical interventions that are designed to prevent HIV infection. Both interventions are highly effective, with 98% effectiveness for PrEP and up to 96% for nPEP with proper adherence.

Allow my Practice to be Listed on PrEP Locator as a Provider of PrEP/nPEP Clinical Care

By checking this box, your practice is agreeing to list your address and location on the national directory, PrEP Locator. This will allow individuals seeking PrEP and PrEP related care in your zip code to find your practice.

PrEP/nPEP Referral. If a provider determines not to offer PrEP/nPEP clinical care, they may refer PrEP/nPEP clients to the Department of Health in Miami-Dade by calling 305-643-7420

  • Physical exam
  • Discuss medication history
  • Review clinical signs and symptoms of HIV infection
  • Refer patient to a Ryan White Service Provider to discuss funding options
  • Reproductive and contraceptive assessment for PrEP users and pregnancy test if applicable
  • Documented negative HIV test(s) within one to two weeks of starting PrEP (antibody-antigen and/or viral load, depending upon recent exposures)
  • Screening for sexually transmitted infections, such as urine tests (chlamydia, gonorrhea), blood tests (herpes, syphilis), or rectal, vaginal, or throat swabs (chlamydia, gonorrhea)
  • Blood work for hepatitis A, B, and C (vaccines recommended if not immune to HAV or HBV, treatment options discussed if current hepatitis disease)
  • Urinalysis of creatinine levels for kidney health
  • Prescription for a 30-day supply of PrEP (sometimes done without refill to assess adherence and side effects)

nPEP: Patients who present as having experienced a high-risk HIV exposure in the last 72 hours are eligible for PEP. Eligible patients must start on medication within 72 hours of exposure. All persons considered for nPEP should undergo HIV testing to determine HIV status, preferably with rapid combined Ag/Ab, or antibody blood tests. If rapid HIV blood test results are unavailable and nPEP is otherwise indicated, it should be initiated without delay and can be discontinued if the patient is later determined to be HIV-positive already or the source is found to be HIV-negative. For further guidance on nPEP clinical implementation, please see the Department of Health’s HIV Non-Occupational Post-Exposure Prophylaxis Clinical Guidelines.

Provide Immediate Antiretroviral Therapy for Patients who Test Positive for HIV

Also known as Test and Treat Rapid Access, this is the standard of care for all patients who have been newly diagnosed as HIV positive or was previously diagnosed as HIV positive and is not currently in care. Within 7 days of receiving an HIV positive diagnosis, the patient should:

  • Visit the clinician for a physical exam
  • Receive a 30-day supply of antiretroviral therapy
  • Obtain baseline lab results (can be ordered prior to visit or on same day that ART is started)
  • Be linked to an HIV primary care provider
  • Be referred to a Ryan White care agency for assistance with eligibility/health insurance coverage and case management services

For further details, please refer to theDepartment of Health’s HIV Test and Treat and Re-engage in Care Guidance (Dec 2020).